A detailed history of Fmr LLC transactions in Adagene Inc. stock. As of the latest transaction made, Fmr LLC holds 1,330,673 shares of ADAG stock, worth $3.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,330,673
Previous 1,348,985 1.36%
Holding current value
$3.99 Million
Previous $3.78 Million 7.78%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$2.12 - $3.24 $38,821 - $59,330
-18,312 Reduced 1.36%
1,330,673 $4.07 Million
Q1 2024

May 13, 2024

BUY
$1.96 - $4.15 $2.4 Million - $5.08 Million
1,224,023 Added 979.52%
1,348,985 $3.78 Million
Q4 2023

Feb 13, 2024

SELL
$1.31 - $1.93 $1.31 Million - $1.93 Million
-1,000,000 Reduced 88.89%
124,962 $241,000
Q2 2022

Aug 12, 2022

SELL
$1.99 - $3.85 $225,289 - $435,862
-113,211 Reduced 9.14%
1,124,962 $2.26 Million
Q1 2022

May 13, 2022

SELL
$3.5 - $8.79 $52,122 - $130,900
-14,892 Reduced 1.19%
1,238,173 $4.42 Million
Q4 2021

Feb 14, 2022

SELL
$7.4 - $14.44 $13,675 - $26,685
-1,848 Reduced 0.15%
1,253,065 $10 Million
Q3 2021

Nov 15, 2021

BUY
$12.7 - $20.68 $15.9 Million - $26 Million
1,254,913 New
1,254,913 $18 Million

Others Institutions Holding ADAG

About Adagene Inc.


  • Ticker ADAG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,423,200
  • Market Cap $130M
  • Description
  • Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...
More about ADAG
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.